THP-1 cell-derived foam cells were exposed to oxidative stress through combined treatment with
acetylated LDL (
acLDL) and
copper ions (Cu2+). The foam cells showed
caspase-dependent apoptotic changes on exposure to oxidative stress for 6 h, and necrotic changes with the leakage of LDH after 24 h.
KY-455, an anti-oxidative ACAT inhibitor, and
ascorbic acid (VC) but not YM-750, an ACAT inhibitor, prevented apoptotic and necrotic changes. These preventive effects of
KY-455 and VC were accompanied by the inhibition of lipid peroxidation in culture medium containing
acLDL and Cu2+, suggesting the involvement of oxidized
acLDL in apoptosis and
necrosis. Foam cells accumulated esterified
cholesterol (EC) for 24 h in the presence of
acLDL without Cu2+, which was suppressed by
KY-455 and YM-750. Foam cells showed necrotic changes and died in the presence of
acLDL and Cu2+.
KY-455 but not YM-750 prevented cell death and reduced the amount of EC accumulated. The foam cells treated with VC further accumulated EC without necrotic changes for 24 h even in the presence of
acLDL and Cu2+. YM-750 as well as
KY-455 inhibited
lipid accumulation when co-incubated with VC in foam cells exposed to oxidative stress. It is concluded that an anti-oxidative ACAT inhibitor or the combination of an
antioxidant and an ACAT inhibitor protects foam cells from oxidative stress and effectively reduces
cholesterol levels, which would be a promising approach in anti-atherosclerotic
therapy.